Core product
OntoGuard Decision Authorization Platform returns ALLOW, BLOCK, or ESCALATE before a proposed AI movement becomes an organizational act.
AI governance for healthcare payer prior authorization, claims, and member communications before administrative outputs affect members or reviewers.
OntoGuard evaluates proposed administrative outputs and workflow movements before release. This page addresses prior-authorization support, claims administration, utilization-management support, and communications. It does not claim autonomous clinical diagnosis, treatment selection, clinical authority, or HIPAA certification.
OntoGuard Decision Authorization Platform returns ALLOW, BLOCK, or ESCALATE before a proposed AI movement becomes an organizational act.
The governed event is not whether language sounds medically plausible. It is whether the output has sufficient evidence, authority, route, and review closure to enter an administrative workflow.
Support language, evidence summaries, missing-information requests, and exception routing before member or provider communication.
Administrative rationale, document-sufficiency review, coding or policy-support summaries, and claim-workflow movement.
Proposed explanations whose release could create confusion, delay, reliance, or a material administrative effect.
Evidence organization and reviewer support that must remain inside delegated authority and the selected review route.
A fluent answer can still be institutionally inadmissible. OntoGuard separates semantic plausibility from authorization to proceed.
The packet identifies the required reviewer function and whether assignment, qualification, and delegated authority are established.
The reviewer sees available evidence, missing records, conflicts, applicability uncertainty, and reason-coded escalation context.
The reviewer may approve, revise, reject, request evidence, or retain the withheld state within the organization’s policy boundary.
The final disposition, reviewer authority, released version, and proof update must be recorded before closure is claimed.
The Decision Authorization Packet records the decision, evidence status, reason codes, review route, release state, no-bind posture, and selected packet artifacts. Buyer-readable PDF and machine-readable JSON make the same governed event inspectable by business, risk, technical, and audit teams.
The evaluation begins by identifying the proposed state transition: for example, draft support language becoming an official member communication, or an evidence summary becoming an input to an administrative determination. BM25 can retrieve candidate passages and exact terminology from approved sources, while semantic and ontology grounding connect those passages to the workflow, evidence type, authority, and consequence. Retrieval rank is not authorization. The decision layer separately tests whether the evidence is sufficient, whether the selected policy context applies, whether the route is permitted, and whether the consequence requires qualified human judgment.
The proposed communication remains withheld. The packet identifies the unresolved evidence, applicability, authority, and reviewer conditions rather than turning uncertainty into a silent release.
The reviewer receives the proposed output, source references, reason codes, evidence gaps, and permitted decision options. The organization—not OntoGuard—defines the reviewer’s qualifications and delegated authority.
An approved revision may become eligible for release, a request for more evidence may retain ESCALATE, or an unsupported proposal may be BLOCKED. The decision and closure state are added to the proof record.
Start with representative, de-identified or synthetic prompts and outputs; the intended audience and downstream operation; workflow labels; available evidence references; the current review path; and examples of accepted, corrected, or rejected outcomes. Do not submit protected health information, customer records, or regulated data through the public form. A scan measures decision and review pressure; it is not a clinical validation, legal opinion, certification, or proof of production endpoint enforcement.